David P. Hesson

TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P

Lynne A. Murray, Qingsheng Chen, Michael S. Kramer et al. · The International Journal of Biochemistry & Cell Biology · 2010 · 359 citations

Inflammation, Fibrosis, Inflammatory Lung Disease +9

Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization

Jack B. Jiang, David P. Hesson, Betsy A. Dusak et al. · Journal of Medicinal Chemistry · 1990 · 261 citations

Tumor Biology, Medicinal Chemistry, Antimitotic Anticancer Agents +14

Serum Amyloid P Therapeutically Attenuates Murine Bleomycin-Induced Pulmonary Fibrosis via Its Effects on Macrophages

Lynne A. Murray, Rogério Silva Rosada, Ana Paula Moreira et al. · PLoS ONE · 2010 · 191 citations · Full text

Inflammatory Lung Disease, Advanced Lung Disease, Lung Inflammation +20

Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors.

Daniel L. Dexter, David P. Hesson, Robert Ardecky et al. · PubMed · 1985 · 104 citations

Molecular Pharmacology, Medicinal Chemistry, Novel 4-Quinolinecarboxylic Acid +15

Substituted 1,2-Dihydrophthalazines:  Potent, Selective, and Noncompetitive Inhibitors of the AMPA Receptor

Jeffrey C. Pelletier, David P. Hesson, Kenneth Jones et al. · Journal of Medicinal Chemistry · 1996 · 94 citations

Drug Target, Altmetric Attention Score, Pharmacotherapy +18